SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-182686
Filing Date
2007-08-14
Accepted
2007-08-14 16:07:30
Documents
9
Period of Report
2007-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 676830
2 AMENDMENT TO LASALLE BANK AGREEMENT DATED APRIL 25, 2007 dex103.htm EX-10.3 15008
3 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 6550
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ERNST & YOUNG LLP dex23a.htm EX-23.(A) 1707
5 POWER OF ATTORNEY dex242.htm EX-24.2 15258
6 SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 8878
7 SECTION 302 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8884
8 SECTION 906 CEO AND CFO CERTIFICATION dex32.htm EX-32 4272
9 GRAPHIC g55401img01.jpg GRAPHIC 54139
  Complete submission text file 0001193125-07-182686.txt   813502
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 071055203
SIC: 2835 In Vitro & In Vivo Diagnostic Substances